Osaic Holdings’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79 Hold
3
﹤0.01% 7853
2026
Q1
$67 Buy
+3
New +$56 ﹤0.01% 7659
2025
Q4
Sell
-47
Closed -$189 8238
2025
Q3
$189 Sell
47
-2
-4% -$7 ﹤0.01% 7700
2025
Q2
$106 Buy
+49
New +$117 ﹤0.01% 7559
2025
Q1
Sell
-883
Closed -$3.73K 7746
2024
Q4
$3.73K Buy
+883
New +$5.51K ﹤0.01% 6342

Other funds holding ANRO

Osaic Holdings's ANRO Position: Q2 2026 in Review

Osaic Holdings held its Alto Neuroscience (ANRO) position steady in Q2 2026 at 3 shares worth $79. The position accounts for ﹤0.01% of the portfolio, ranked #7853.

Osaic Holdings first reported a position in ANRO in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.73K in Q4 2024. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Osaic Holdings held 3 shares of Alto Neuroscience worth $79 as of Q2 2026.
  • Osaic Holdings left its Alto Neuroscience share count unchanged in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7853 holding.
  • Osaic Holdings first reported a position in Alto Neuroscience in Q4 2024 and has held it in 5 quarters since.
  • Osaic Holdings's Alto Neuroscience position peaked at $3.73K in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.